Matteo Pavoni

MATTEO PAVONI

Cittadinanza: Italiana

Data di nascita: 06/02/1993

Sesso: Maschile

FORMAZIONE

Specialista in Microbiologia e Virologia. Abilitazione all'esercizio della professione di Biologo, Università Politecnica delle Marche. Laurea in Biologia della salute (LM-6) presso l'Università degli Studi di Bologna 2017. Laurea triennale in Scienze Biologiche (L-13) presso l'Università Politecnica delle Marche 2015.

ATTIVITA' SCIENTIFICA

PUBBLICAZIONI SCIENTIFICHE EDITE DA PUBMED

2017

Fiorini G, Saracino IM, Zullo A, Gatta L, Pavoni M, Vaira D.

Rescue therapy with bismuth quadruple regimen in patients with Helicobacter pylori- resistant strains.

Helicobacter 2017;22; .(I.F. 3.4).

2018

Fiorini G, Zullo A, Saracino IM, Pavoni M, Vaira D.

Antibiotic resistance pattern of Helicobacter pylori strains isolated in Italy

during 2010-2016. Scan J Gastroenterol 2018 JUN (53): 6 661-664 (I.F. 2.3)

Fiorini G., Zullo A., Saracino I.M., Gatta L., Pavoni M., Vaira D.

Pylera and sequential therapy for first-line H. pylori eradication: a culture-based study in real clinical pactice. European Journal of Gastroenterology & Hepatology 2018; 30; 621-25. (I.F.2)

2019

Ferdinando D’Amico, Giulia Fiorini, Antonio Tursi, Ilaria Maria Saracino, Matteo Pavoni, Silvio Danese, Dino Vaira. Efficacy of a new nutraceutical formulation in patients with symptomatic uncomplicated diverticular disease (SUDD): A prospective observational study. Journal of Gastrointestinal and Liver Diseases 2019 28, pp. 49-52. (I.F. 2.1).

De Francesco, Vincenzo; Zullo, Angelo; Fiorini, Giulia; Saracino, Ilaria; Pavoni, Matteo; Vaira, Dino. Role of minimal inhibitor concentration (MIC) levels towards clarithromycin and metronidazole resistance on H. pylori eradication. J Antimicrob Chemother. 2019 Mar 1;74(3):772-774. (I.F.5.2)

2020

Fiorini G, Saracino IM., Zullo A, Pavoni M., Saccomanno L., Lazzarotto T., Cavallo R., Antonelli G., Vaira D. Antibiotic resistance and therapy for H.pylori infection in immigrant patients managed in Italy.

Journal of Clinical Medicine 2020 9 (5),1299. Epub ahead of print (I.F.5.8)

Matteo Pavoni*, Ilaria Maria Saracino*, Laura Saccomanno, Giulia Fiorini,

Valeria Pesci, Claudio Foschi, Giulia Piccirilli, Giulia Bernardini , John Holton,

Natale Figura, Tiziana Lazzarotto, Claudio Borghi and Berardino Vaira

Antimicrobial efficacy of five probiotic strains against Helicobacter pylori. Antibiotics 2020, 9(5), 244. (I.F. 3.9)

Saracino I.M., Fiorini G., Zullo A., Pavoni M., Saccomanno L. and Vaira D. Trends in Primary Antibiotic Resistance in H. pylori Strains isolated in Italy between 2009 and 2019.

Antibiotics 2020, 9(1), 26. (IF 3.9)

A.Zullo, G.Fiorini, G.Bassotti, F.Bachetti, F.Monica, D.Macor, A.O.Paoluzi, G.Scaccianoce, P.Porticasa, V.DeFrancesco, R.Lorenzetti, I.M.Saracino, M.Pavoni, D.Vaira. Upper endoscopy in patients with extra-oesophageal reflux symptoms: a multicenter study.GE Portuguese Journal of Gastroenterology, 2020, 27(5), pp. 312-317(IF 0.47)

Pavoni M*., Saracino IM*., Zullo A., Fiorini G., Saccomanno L., Lazzarotto T., Cavallo R., Antonelli G., Vaira D. Antibiotic resistance and therapy outcome in H.pylori eradication failure patients.

Antibiotics 2020 Mar 13;9(3):121 (IF 3.9)

Matteo Pavoni*, Ilaria Maria Saracino*, Angelo Zullo, Giulia Fiorini, Laura Saccomanno, Tiziana Lazzarotto, Guido Antonelli, Rossana Cavallo, Claudio Borghi and Berardino Vaira. Rescue therapies for H. pylori infection in foreign patients treated in Italy.

JCG 2020 Epub ahead of print doi: 10.1097/MCG.0000000000001457. (I.F. 2.7)

 Matteo Pavoni*, Ilaria M. Saracino*, Angelo Zullo, Giulia Fiorini, Laura Saccomanno, Tiziana Lazzarotto, Guido Antonelli, Rossana Cavallo, Claudio Borghi and Dino Vaira. Rifabutin-based triple therapy or bismuth-based quadruple regimen as rescue therapies for Helicobacter pylori infection.

EJIM 2020 Volume 81, November 2020, Pages 50-53 (I.F. 3.6)

 Fiorini G., Saracino I.M, Pavoni M. Saccomanno L Vaira D. Efficacy of a new nutraceutical formulation (CHETOGERD) in patients with nonerosive reflux (NERD): a prospective observational study.

Intern Emerg Med. 2020,15(7),pp. 1265-1269 (I.F. 2.5).

2021

Chiereghin Angela, Zagari Rocco Maurizio, Galli Silvia, Moroni Alessandra, Gabrielli Liliana, Venturoli Simona, Bon Isabella, Rossini Giada, Saracino Ilaria Maria, Pavoni Matteo, Lafratta Silvia, Deni Alessandro, Felici Silvia, Borghi Michele, Guerra Luca, Raumer Luigi, Lodi Vittorio, Viale Pierluigi, Attard Luciano, Lazzarotto Tiziana, IRCCS St. Orsola Polyclinic of Bologna COVID-19 Research Team Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19. Frontiers in Public Health. 2021, 10.3389/fpubh.2020.620222 ISSN=2296-2565 (I.F. 2.5).

Pavoni, Matteo*; Saracino, Ilaria M*.; Zullo, Angelo; Fiorini, Giulia; Lazzarotto, Tiziana; Borghi, Claudio; Vaira, Dino.
Next Generation Sequencing for the Prediction of the Antibiotic Resistance in Helicobacter pylori: A Literature Review. Antibiotics 2021, 10, no. 4: 437. https://doi.org/10.3390/antibiotics10040437 (I.F. 4.6).

De Francesco V, Zullo A, Gatta L, Manta R, Pavoni M, Saracino IM, Fiorini G, Vaira D. Rescue Therapies for H. pylori Infection in Italy. Antibiotics. 2021; 10(5):525. https://doi.org/10.3390/antibiotics10050525 (I.F. 4.6).

Lanari, M., Biserni, G. B., Pavoni, M., Borgatti, E. C., Leone, M., Corsini, I., Lazzarotto, T. (2021). Feasibility and Effectiveness Assessment of SARS-CoV-2 Antigenic Tests in Mass Screening of a Pediatric Population and Correlation with the Kinetics of Viral Loads. Viruses, 13(10), 2071. https://doi.org/10.3390/v13102071 (I.F. 5.1)

2022

De Francesco V., Zullo A., Manta R., Pavoni M., Saracino I.M., Fiorini G., Giosrra F., monti G., Vaira D. First line therapies for Helicobacter pylori infection in Italy: a pooled-data analysis. Eur J gastroentreol Hepatol 2022 IF 2.251

Saracino IM, Foschi C, Pavoni M, Spigarelli R, Valerii MC, Spisni E. Antifungal Activity of Natural Compounds vs. Candida spp.: A Mixture of Cinnamaldehyde and Eugenol Shows Promising In Vitro Results. Antibiotics (Basel). 2022 Jan 8;11(1):73. doi: 10.3390/antibiotics11010073. PMID: 35052950; PMCID: PMC8773119.

Francesco V, Zullo A, Manta R, Satriano A, Fiorini G, Pavoni M, Saracino IM, Giostra F, Monti G, Vaira D. Culture-based antibiotic susceptibility testing for Helicobacter pylori infection: a systematic review. Ann Gastroenterol. 2022 Mar-Apr;35(2):127-134. doi: 10.20524/aog.2022.0689. Epub 2022 Feb 14.

2023

Gabrielli L, Balboni A, Borgatti EC, Virgili G, Petrisli E, Cantiani A, Pavoni M, Baiesi Pillastrini F, Venturoli S, Piccirilli G, Lazzarotto T. Inherited Chromosomally Integrated Human Herpesvirus 6: Laboratory and Clinical Features. Microorganisms. 2023 Feb 21;11(3):548. doi: 10.3390/microorganisms11030548. PMID: 36985122; PMCID: PMC10052293.

Gatta L, Nyssen OP, Fiorini G, Saracino IM, Pavoni M, Romano M, Gravina AG, Granata L, Pellicano R, Gasbarrini A, Di Leo A, Losurdo G, Franceschi F, Nardone G, Rocco A, Dore MP, Farinati F, Ghisa M, Bellini M, Holton J, Puig I, Vaira D, Borghi C, Mégraud F, O'Morain C, Gisbert JP. Effectiveness of first and second-line empirical treatment in Italy: Results of the European registry on Helicobacter pylori management. United European Gastroenterol J. 2023 Feb;11(1):103-113. doi: 10.1002/ueg2.12348. Epub 2022 Dec 23. PMID: 36565017; PMCID:PMC9892436.

Fiorini G, Saracino IM, Pavoni M, Nipote B, Colucci R, Capone P, Sannino A, Forte F, DE Vergori E, Brancaccio M, Cesareo M, Casella G, Morreale GC, Bonfrate L, Portincasa P, Vincenzi M, Cottone C, Ormando VM, Scalise N, Lawson PF, Burattini O, Montale A, Luzza F, Rossi M, Vanni R, Bozzi R, Vincoli G, Stefani N, Borghi C, Vaira D. Efficacy of a new nutraceutical formulation: L-tryptophan, probiotics, charcoal, chamomile, mint, and licorice (COLONIR®) in the improvement of gastrointestinal symptoms in subjects with irritable bowel syndrome. Minerva Gastroenterol (Torino). 2023 Mar;69(1):123-127. doi: 10.23736/S2724-5985.22.03282-X.PMID:36856276.

Bonazzetti C, Tazza B, Gibertoni D, Pasquini Z, Caroccia N, Fanì F, Fornaro G, Pascale R, Rinaldi M, Miani B, Gamberini C, Morelli MC, Tamé M, Busutti M, Comai G, Potena L, Borgese L, Salvaterra E, Lazzarotto T, Scudeller L, Viale P, Giannella M; CONTRAST Study Group. Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort. Clin Infect Dis. 2023 May 24;76(10):1761-1767. doi: 10.1093/cid/ciad016. PMID: 36636955; PMCID: PMC10209432.

Giulia Piccirilli, Alessandro Rocca, Eva C. Borgatti, Liliana Gabrielli, Daniele Zama Luca Pierantoni, Marta Leone, Camilla Totaro, Matteo Pavoni, Tiziana Lazzarotto, Marcello Lanari. Respiratory Syncytial Virus-Load Kinetics and Clinical Course of Acute Bronchiolitis in Hospitalized Infants: Interim Results and Review of the Literature. Pathogens 2023, 12, 645. https://doi.org/10.3390/pathogens1205064

Nyssen, O.P.; Pratesi, P.; Spínola, M.A.; Jonaitis, L.; Pérez-Aísa, Á.; Vaira, D.; Saracino, I.M.; Pavoni, M.; Fiorini, G.; Tepes, B.; et al. Analysis of Clinical Phenotypes through Machine Learning of First-Line H. pylori Treatment in Europe during the Period 2013–2022: Data from the European Registry on H. pylori Management (Hp-EuReg). Antibiotics 2023, 12, 1427. https://doi.org/10.3390/antibiotics12091427

Pavoni, M., Principe, L., Foschi, C., Meroni, E., Briozzo, E., Lazzarotto, T., Ambretti, S., & Di Bella, S. (2023). Antimicrobial Resistance of Genital Mycoplasma and Ureaplasma: A Multicentre Study Over a 5-Year Period in Italy (2017-2021). Microbial drug resistance (Larchmont, N.Y.), 10.1089/mdr.2023.0202. Advance online publication. https://doi.org/10.1089/mdr.2023.0202

PUBBLICAZIONI IN ITALIANO

Giulia Fiorini, Ilaria Maria Saracino, Laura Saccomanno, Matteo Pavoni, Dino Vaira.

Efficacia del bifidobacterium breve e del Lactobacillus Rhamnosus come coadiuvanti nell’eradicazione dell’Helicobacter pylori in pazienti naive.

FARMACI 2017 vol 16 pg 1-8

ABSTRACT ACCETTATI COME ORAL PRESENTATION IN CONGRESSI INTERNAZIONALI

• 1Oral Presentation Saracino I.M., Pavoni M., Fiorini G., Saccomanno L., Bibbs D.,Vaira D.

  Evaluation of Curian HpSA Fluorometric assay. A novel, rapid immunoassay for the dectection of Helicobacter pylori antigens in human stool.

  Kaunas 2018 Abstract W1.1 Helicobacter 23 (suppl 1) 31° International Workshop on Helicobacter& Microbiota in Inflammation & Cancer

  Presenting author: Matteo Pavoni

• 2Oral Comunication G. Fiorini, A. Zullo, I.M. Saracino, L. Gatta, M. Pavoni, B. Vaira. PYLERA AND SEQUENTIAL THERAPY FOR FIRST-LINE H. PYLORI ERADICATION: A CULTURE-BASED STUDY IN REAL CLINICAL PRACTICE [https://www.researchgate.net/publication/323864217_OC145_PYLERA_AND_SEQUENTIAL_THERAPY_FOR_FIRST-LINE_H_PYLORI_ERADICATION_A_CULTURE-BASED_STUDY_IN_REAL_CLINICAL_PRACTICE?_sg=AmOoK5vi8LtsqXH9Z-OQabmdYtu-WBCkydoX9EVWnMFi4waqTMi7SFk1lawIRP27ay2Yd2MXuqljme99EzXlnFL9TAfKeb0q8g9g1IsM.H8Rg2v01PfunI8GeXqverTBBhNHznLPocWW1vwDjfR4O8ZbAQfyXBDv5sltnladUONLDX-CAQxDAaplclNJiVQ] 24° CNMD FISMAD 21-24 marzo 2018, Roma. March 2018 OC.14.5, Digestive and Liver Disease 50(2):e105
• 3Oral Communication Pavoni M., Turello G., Saracino I.M., Fiorini G., Saccomanno L., Lazzarotto T., Vaira B., Beckman E. PCR Test for Helicobacter pylori detection and Clarithromycin Resistance prediction on fecal and bioptic samples: comparison of accuracies. 25° CNMD FISMAD 27-30 marzo 2019, Roma. Digestive and Liver Disease, Volume 51, Supplement 2, 25 March 2019, Pages e106-e107
• 4Oral Communication Zagari, R; Romiti, A; Fiorini, G; Saracino, I; Ribaldone, D; Panarese, A; Lella, F; Gigliotti, F; Gasbarrini, A; Paoluzi, O; Blanco, GD; Romano, M; Annibale, B; Broglia, L; Catanzaro, R; Hervoso, CM; Luzza, F; Nardone, G; Conigliaro, R; Cannizzaro, R; Pavoni, M; Vaira, B; Pellicano, R; Ferrara, M; Bazzoli, F. XXXIInd Workshop of the European Helicobacter and Microbiota Study Group Use of probiotics in the Helicobacter pylori eradication in Italy: data from the Italian Registry on Helicobacter pylori treatment Helicobacter vol 24 suppl 1, 38-39
• 5Oral Comunication. Pavoni M., Turello G., Saracino I.M., Fiorini G., Saccomanno L., Lazzarotto T., Vaira B., Beckman E.

  PCR Test for Helicobacter pylori detection and Clarithromycin Resistance prediction on fecal and bioptic samples: comparison of accuracies. 119° Congresso SIMI Roma 26-28, October 2018 Internal and emergency medicine [in press]

• 6Oral presentation Pavoni M., Turello G., Saracino I.M., Fiorini G., Saccomanno L., Lazzarotto T., Vaira B., Beckman E.

  PCR Test for Helicobacter pylori detection and Clarithromycin Resistance prediction on fecal and bioptic samples: comparison of accuracies. UEG week 2018. 20-24 ottobre, Vienna. UEG journal 2018: 6 (8S) pg A64

• 727° CNMD FISMAD virtual event 22-25 settembre 2021

  OC.08.1

  RESCUE THERAPIES FOR H. PYLORI INFECTION IN ITALY

  V. De Francesco, A. Zullo, L. Gatta, R. Manta, M. Pavoni, I.M. Saracino, G. Fiorini, B. Vaira

• 8OC.08.2

  EFFECTIVENESS OF EMPIRICAL FIRST-LINE H. PYLORI ERADICATION THERAPY IN

  ITALY: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT

  (HP-EUREG)

  L. Gatta, G. Fiorini, I.M. Saracino, M. Pavoni, M. Romano, A.G. Gravina, L. Granata, R. Pellicano, A. Gasbarrini, A. Di Leo, G. Losurdo, F. Franceschi, G. Nardone, A. Rocco, M.P. Dore, F. Farinati, M. Ghisa, I. Puig, O. Nyssen, F. Mégraud, C. O'Morain, D. Vaira, J. Gisbert

• 9OC.08.4

  ANTIBIOTIC RESISTANCE TRENDS OF ITALIAN H. PYLORI NAÏVE PATIENTS

  BETWEEN 2013-2020: ANALYSIS OF THE EUROPEAN REGISTRY ON H. PYLORI

  MANAGEMENT (HP-EUREG)

  L. Gatta, G. Fiorini, I.M. Saracino, M. Pavoni, M. Romano, A.G. Gravina, L. Granata, R. Pellicano, A. Gasbarrini, A. Di Leo, G. Losurdo, F. Franceschi, G. Nardone, A. Rocco, M.P. Dore, F. Farinati, M. Ghisa, I. Puig, O. Nyssen, M. Francis, C. O'Morain, D. Vaira, J. Gisbert

• 10OC.08.5 EFFECTIVENESS OF EMPIRICAL SECOND-LINE H. PYLORI ERADICATION THERAPY IN ITALY: RESULTS FROM THE EUROPEAN REGISTRY ON H. PYLORI MANAGEMENT(HP-EUREG) L. Gatta, G. Fiorini, I.M. Saracino, M. Pavoni, M. Romano, A.G. Gravina, L. Granata, R. Pellicano, A. Gasbarrini, A. Di Leo, G. Losurdo, F. Franceschi, G. Nardone, A. Rocco, M.P. Dore, F. Farinati, M. Ghisa, I. Puig, O. Nyssen, M. Francis, C. O'Morain, D. Vaira, J. Gisbert

ABSTRACT ACCETTATI COME POSTER PRESENTATION IN CONGRESSI INTERNAZIONALI

• 1Zagari, R.M. Romiti, A. Saracino, Ilaria Pavoni, Matteo Ribaldone, Davide Giuseppe Panarese, A. Lella, F Gigliotti, F Gasbarrini, Antonio Del Vecchio Balnco, Giovanna Paoluzi, Omero Romano, Marco Annibale, Bruno Broglia, L Catanzaro, R. Hervoso, C. Luzza, Francesco Nardone, G. Grande, Giuseppe Conigliaro, Rita Bazzoli, F. USE OF PROBIOTICS IN THE HELICOBACTER PYLORI ERADICATION IN ITALY: DATA FROM THE “ITALIAN REGISTRY” ON H. PYLORI TREATMENT (2020). Digestive and Liver Disease. 52. S80-S81. 10.1016/S1590-8658(20)30673-3. XXXIInd Workshop of the European Helicobacter and Microbiota Study Group
• 2Poster presentation Pavoni M., Turello G., Saracino I.M., Fiorini G., Saccomanno L., Lazzarotto T., Vaira B., Beckman E.

  PCR Test for Helicobacter pylori detection and Clarithromycin Resistance prediction on fecal and bioptic samples: comparison of accuracies.

  Kaunas 2018 Poster P01.18 Helicobacter 23 (suppl 1) 31° International Workshop on Helicobacter& Microbiota in Inflammation & Cancer

• 3Poster presentation G.Fiorini, I.M.Saracino, A.Zullo, L.Gatta, M.Pavoni, D.Vaira.

  Rescue therapy with bismuth quadruple regimen in patients with H. pylori resistant strains.

  Kaunas 2018 Poster P02.35 Helicobacter 23 (suppl 1) 31° International Workshop on Helicobacter& Microbiota in Inflammation & Cancer

• 4Poster presentation G.Fiorini, A.Zullo, I.M.Saracino, L.Gatta, M.Pavoni, D.Vaira.

  Pylera and sequential therapy for first-line H. pylori eradication: a culture-based study in real clinicalpractice.

  Kaunas 2018 Poster P06.14 Helicobacter 23 (suppl 1). 31° International Workshop on Helicobacter& Microbiota in Inflammation & Cancer

• 5Poster presentation G. Fiorini, I.M. Saracino, L. Saccomanno, M. Pavoni, B. Vaira.

  BIFIDOBACTERIUM BREVE AND LACTOBACILLUS RHAMNOSUS EFFICACY AS COADJUVANTS IN THE HELICOBACTER PYLORI ERADICATION IN NAÏVE PATIENTS.

  March 2018,Poster P.06.7 Digestive and Liver Disease 50(2):e181

• 6Poster presentation F. D’Amico, G. Fiorini, A. Turisi, I.M. Saracino, M. Pavoni, S. Danese, D. Vaira. EFFICACY OF DIVER-100 IN PATIENTS WITH SYMPTOMATIC UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): PRELIMINARY RESULTS FROM A PROSPECTIVE OBSERVATIONAL COHORT [https://www.researchgate.net/publication/323860221_P0517_EFFICACY_OF_DIVER-100_IN_PATIENTS_WITH_SYMPTOMATIC_UNCOMPLICATED_DIVERTICULAR_DISEASE_SUDD_PRELIMINARY_RESULTS_FROM_A_PROSPECTIVE_OBSERVATIONAL_COHORT?_sg=159pHvBemw3wwgTuYWFN7VGPECXBicVbPQW_eohDUE3jesQ-z3sMA-3cChaiuTnElz4uMy3xnWhZUx0KeC9Trl5UH3y-Y9TT-Lc_FxeA.ic2GJsA9210IDzihv_q-03-B4m_ffQHi_VJ8ACCvloEkAbKHgukzTgIsgANJvgs_72O8aX0QVXPGdmNaglxQdw] . March 2018, Poster P.05.17, Digestive and Liver Disease 50(2):e172-e173.
• 7Poster presentation G. Fiorini, I.M. Saracino, A. Zullo, L. Gatta, M. Pavoni, B. Vaira. RESCUE THERAPY WITH BISMUTH QUADRUPLE REGIMEN IN PATIENTS WITH HELICOBACTER PYLORI -RESISTANT STRAINS. March 2018, Poster P.10.10 Digestive and Liver Disease 50(2):e232.
• 8Poster presentation G. Fiorini, A. Zullo, I.M. Saracino, L. Gatta, M. Pavoni, B. Vaira. H. PYLORI RESISTANCE STATUS AND EFFICACY OF SEQUENTIAL THERAPY FOR FIRST-LINE THERAPY: A 6-YEAR EXPERIENCE IN A SINGLE ITALIAN CENTER. March 2018 Poster P.01.21, Digestive and Liver Disease 50(2):e128
• 9Poster Presentation Saracino I.M., Pavoni M., Fiorini G., Saccomanno L., Bibbs D.,Vaira D.

  Evaluation of Curian HpSA Fluorometric assay. A novel, rapid immunoassay for the dectection of Helicobacter pylori antigens in human stool.

  UEG journal 2018 6(8S) pgA528

• 10Poster presentation G.Fiorini, A.Zullo, I.M.Saracino, L.Gatta, M.Pavoni, D.Vaira.

  Pylera and sequential therapy for first-line H. pylori eradication: a culture-based study in real clinicalpractice.

  UEG journal 2018 6(8S) pgA730

• 11Poster presentation G.Fiorini, I.M.Saracino, A. Zullo, L.Gatta, M.Pavoni, D.Vaira.

  Bismuth quadruple regimen as rescue therapy in patients with Helicobacter Pylori-resistant strains

  UEG journal 2018 6(8S)

• 1225° CNMD FISMAD 27-30 Marzo 2019 Roma

  I.M. Saracino, M. Pavoni, G. Fiorini, L. Saccomanno, D. Bibbs, B. Vaira Evaluation of Curian HpSA fluorimetric assay, a novel, rapid immunoassay for the detection of Helicobacter pylori antigens in human stool.

  Digestive and liver disease Volume 51, Supplement 2, 25 March 2019, Pages e137-e138

• 13XLVIII CONGRESSO NAZIONALE AMCLI – Rimini, 9-12 novembre 2019 M. Pavoni, L. Saccomanno, I.M. Saracino, G. Fiorini and D. Vaira.

  COMPARISON OF TRENDS IN ANTIBIOTIC RESISTANCE AND ERADICATION RATES IN H PYLORI STRAINS ISOLATED BETWEEN 2009 AND 2019

• 14120° Congresso Nazionale SIMI Roma, 18-20 ottobre 2019

  Efficacy of a new nutraceutical formulation in Symptomatic Uncomplicated Diverticular Disease: a prospective study F. D’Amico, G. Fiorini, A. Tursi, I. M. Saracino, M. Pavoni, S. Danese, D. Vaira

• 15Zagari, R.M. Romiti, A. Saracino, Ilaria Pavoni, Matteo Ribaldone, Davide Giuseppe Panarese, A. Lella, F Gigliotti, F Gasbarrini, Antonio Del Vecchio Balnco, Giovanna Paoluzi, Omero Romano, Marco Annibale, Bruno Broglia, L Catanzaro, R. Hervoso, C. Luzza, Francesco Nardone, G. Grande, Giuseppe Conigliaro, Rita Bazzoli, F. USE OF PROBIOTICS IN THE HELICOBACTER PYLORI ERADICATION IN ITALY: DATA FROM THE “ITALIAN REGISTRY” ON H. PYLORI TREATMENT (2020). Digestive and Liver Disease. 52. S80-S81. 10.1016/S1590-8658(20)30673-3.
• 16120° Congresso Nazionale SIMI Roma, 18-20 ottobre 2019

Prevalence of gastro-oesophageal lesions in patients with atypical reflux symptoms: a multicenter study.

PREMI

Premio di ricerca, 119° congresso SIMI, Roma 26-28 ottobre 2018

Fiorini G., Saracino I.M., Pavoni M., Vaira D.

Cellule staminali Lgr5+ nel cancro gastrico di tipo intestinale e nelle fasi pre-neoplastiche.

EVENTI FORMATIVI ECM

• 1Ordine Provinciale dei Medici Chirurghi e degli Odontoiatri di Bologna

Provider Nazionale n. 3744

INTEGRATORI ALIMENTARI

Come reagisce il nostro microbiota intestinale?

Se e quanto gli integratori alimentari possono rinforzare e proteggere

il nostro confine intestinale

Sabato 6 ottobre 2018

Sala Conferenze del Circolo Ufficiali dell’Esercito

Via Marsala n. 12 Bologna